158 related articles for article (PubMed ID: 37805556)
1. ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma.
Yuan X; He Y; Wang W
Sci Rep; 2023 Oct; 13(1):16932. PubMed ID: 37805556
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the differential expression and prognostic value of COL1A2 in colon adenocarcinoma.
Jin JJ; Zheng T; Xu XX; Zheng L; Li FY; Li XX; Zhou L
Aging (Albany NY); 2022 Sep; 14(18):7390-7407. PubMed ID: 36057263
[TBL] [Abstract][Full Text] [Related]
3. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs-based high KIF26B expression correlates with poor prognosis and tumor immune infiltration in colon cancer.
Liu Z; Zhou X; Chen B; Wu Z; Zhang C; Gu C; Li J; Yang X
Cell Cycle; 2023; 22(14-16):1726-1742. PubMed ID: 37436127
[TBL] [Abstract][Full Text] [Related]
5. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
6. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analyses of Stromal-Immune Score-Related Competing Endogenous RNA Networks In Colon Adenocarcinoma.
Tong Y; Peng M; Li J; Niu Y
Dis Markers; 2022; 2022():4235305. PubMed ID: 35607443
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma.
Tung CB; Li CY; Lin HY
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948431
[TBL] [Abstract][Full Text] [Related]
12. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
Chen Y; Tian Z; Hou H; Gai W
BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
[TBL] [Abstract][Full Text] [Related]
13. ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.
Jia Z; Wan X
Front Cell Dev Biol; 2022; 10():792564. PubMed ID: 35237596
[No Abstract] [Full Text] [Related]
14. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics and validation reveal SOX12 as potential biomarker in colon adenocarcinoma based on an immune infiltration-related ceRNA network.
Chen X; Yang M; Tu J; Yuan X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15737-15762. PubMed ID: 37668799
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment.
Xu Y; Tang Q; Ding N; Zhang T; Luo H
PeerJ; 2023; 11():e15476. PubMed ID: 37304867
[TBL] [Abstract][Full Text] [Related]
17. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD).
Wang L; Cao Y; Guo W; Xu J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):15-24. PubMed ID: 36173462
[TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
19. Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma.
Wang C; Zhao Z; Zhang Y; Liang W; Zhou C; Lin W; He Y; Wu M; Meng Z; Liao Y; Li M; El Akkawi M; Zhao J; He Y
Front Immunol; 2022; 13():1043512. PubMed ID: 36304472
[TBL] [Abstract][Full Text] [Related]
20. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
Huang X; Cao Y; Bao P; Zhu B; Cheng Z
Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]